TIMOLOL MLPL 0.5% timolol (as maleate) 5 mg/mL eye drops solution bottle Australia - English - Department of Health (Therapeutic Goods Administration)

timolol mlpl 0.5% timolol (as maleate) 5 mg/ml eye drops solution bottle

micro labs pty ltd - timolol maleate, quantity: 6.8 mg/ml (equivalent: timolol, qty 5 mg/ml) - eye drops, solution - excipient ingredients: benzalkonium chloride; water for injections; dibasic sodium phosphate dodecahydrate; sodium hydroxide; monobasic sodium phosphate dihydrate - timolol ophthalmic solution is indicated for the reduction of elevated intraocular pressure.,in clinical trials it has been shown to reduce intraocular pressure in:,patients with ocular hypertension,patients with chronic open-angle glaucoma,aphakic patients with glaucoma

TIMOLOL B&B 0.5% timolol (as maleate) 5 mg/mL eye drops solution bottle Australia - English - Department of Health (Therapeutic Goods Administration)

timolol b&b 0.5% timolol (as maleate) 5 mg/ml eye drops solution bottle

micro labs pty ltd - timolol maleate, quantity: 6.8 mg/ml (equivalent: timolol, qty 5 mg/ml) - eye drops, solution - excipient ingredients: water for injections; monobasic sodium phosphate dihydrate; sodium hydroxide; benzalkonium chloride; dibasic sodium phosphate dodecahydrate - timolol ophthalmic solution is indicated for the reduction of elevated intraocular pressure.,in clinical trials it has been shown to reduce intraocular pressure in:,patients with ocular hypertension,patients with chronic open-angle glaucoma,aphakic patients with glaucoma

TIMOLOL GFS- timolol maleate solution, gel forming / drops United States - English - NLM (National Library of Medicine)

timolol gfs- timolol maleate solution, gel forming / drops

sandoz inc - timolol maleate (unii: p8y54f701r) (timolol anhydrous - unii:5jky92s7br) - timolol anhydrous 5 mg in 1 ml - timolol gfs 0.25% and 0.5% are indicated for the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma. timolol gfs is contraindicated in patients with: • bronchial asthma • history of bronchial asthma • severe chronic obstructive pulmonary disease • sinus bradycardia • second or third degree atrioventricular block • overt cardiac failure • cardiogenic shock • hypersensitivity to any component of this product. teratogenic effects pregnancy category c: teratogenicity studies with timolol in mice, rats, and rabbits at oral doses up to 50 mg/kg/day (7,000 times the systemic exposure following the maximum recommended human ophthalmic dose) demonstrated no evidence of fetal malformations. although delayed fetal ossification was observed at this dose in rats, there were no adverse effects on postnatal development of offspring. doses of 1,000 mg/kg/day (142,000 times the systemic exposure following the maximum recommended human ophthalmic dose) were maternotoxic in

Latanoprost/Timolol AN 50/5 latanoprost 50 microgram/mL + timolol (as maleate) 5 mg/mL eye drop solution bottle Australia - English - Department of Health (Therapeutic Goods Administration)

latanoprost/timolol an 50/5 latanoprost 50 microgram/ml + timolol (as maleate) 5 mg/ml eye drop solution bottle

juno pharmaceuticals pty ltd - latanoprost,timolol maleate -

Latanoprost/Timolol Sandoz 50/5 latanoprost 50 microgram/mL timolol 5 mg/mL Eye Drops Australia - English - Department of Health (Therapeutic Goods Administration)

latanoprost/timolol sandoz 50/5 latanoprost 50 microgram/ml timolol 5 mg/ml eye drops

sandoz pty ltd - latanoprost,timolol maleate -

TIMOLOL MALEATE- timolol solution/ drops United States - English - NLM (National Library of Medicine)

timolol maleate- timolol solution/ drops

akorn - timolol (unii: 817w3c6175) (timolol anhydrous - unii:5jky92s7br) - timolol anhydrous 2.5 mg in 1 ml - timolol is indicated in the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma. timolol is contraindicated in patients with overt heart failure, cardiogenic shock, sinus bradycardia, second- or third-degree atrioventricular block, bronchial asthma or history of bronchial asthma, or severe chronic obstructive pulmonary disease, or hypersensitivity to any component of this product.

Dorzolamide/Timolol EG 20 mg/ml - 5 mg/ml eye drops sol. dropper cont. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

dorzolamide/timolol eg 20 mg/ml - 5 mg/ml eye drops sol. dropper cont.

eg sa-nv - timolol maleate 6,83 mg/ml - eq. timolol 5 mg/ml; dorzolamide hydrochloride 22,26 mg/ml - eq. dorzolamide 20 mg/ml - eye drops, solution - 20 mg/ml - 5 mg/ml - timolol maleate 6.83 mg/ml; dorzolamide hydrochloride 22.26 mg/ml - timolol, combinations

JAMP DORZOLAMIDE-TIMOLOL SOLUTION Canada - English - Health Canada

jamp dorzolamide-timolol solution

jamp pharma corporation - dorzolamide (dorzolamide hydrochloride); timolol (timolol maleate) - solution - 20mg; 5mg - dorzolamide (dorzolamide hydrochloride) 20mg; timolol (timolol maleate) 5mg - beta-adrenergic agents

DORZOLAMIDE/TIMOLOL SANDOZ 20/5 dorzolamide (as hydrochloride) 20 mg/mL and timolol (as maleate) 5 mg/mL eye drops solution bott Australia - English - Department of Health (Therapeutic Goods Administration)

dorzolamide/timolol sandoz 20/5 dorzolamide (as hydrochloride) 20 mg/ml and timolol (as maleate) 5 mg/ml eye drops solution bott

sandoz pty ltd - dorzolamide hydrochloride,timolol maleate -

TIMOLOL MALEATE solution/ drops United States - English - NLM (National Library of Medicine)

timolol maleate solution/ drops

pacific pharma, inc. - timolol maleate (unii: p8y54f701r) (timolol anhydrous - unii:5jky92s7br) - timolol anhydrous 2.5 mg in 1 ml - timolol maleate ophthalmic solution is indicated in the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma. timolol maleate is contraindicated in patients with (1) bronchial asthma; (2) a history of bronchial asthma; (3) severe chronic obstructive pulmonary disease (see warnings); (4) sinus bradycardia; (5) second or third degree atrioventricular block; (6) overt cardiac failure (see warnings); (7) cardiogenic shock; or (8) hypersensitivity to any component of this product.